0

Journal Articles

in Myocardial Infarction
 41-60 of 458 Articles
JAMA Internal Medicine | 
Invited Commentary |  September 10, 2012
Myocardial Infarction Rule-out in the Emergency Department: Are High-Sensitivity Troponins the Answer?:  Comment on “One-Hour Rule-out and Rule-in of Acute Myocardial Infarction Using High-Sensitivity Cardiac Troponin T”
L. Kristin Newby, MD, MHS
Arch Intern Med. 2012;172(16):1218-1219. doi:10.1001/archinternmed.2012.1808.
JAMA Internal Medicine | 
Original Investigation |  September 10, 2012
One-Hour Rule-out and Rule-in of Acute Myocardial Infarction Using High-Sensitivity Cardiac Troponin T
Tobias Reichlin, MD; Christian Schindler, PhD; Beatrice Drexler, MD; et al.
Arch Intern Med. 2012;172(16):1211-1218. doi:10.1001/archinternmed.2012.3698.
INCLUDES: CME , Supplemental Content
JAMA Internal Medicine | 
Original Investigation |  September 10, 2012
Timing of Acute Myocardial Infarction in Patients Undergoing Total Hip or Knee Replacement:  A Nationwide Cohort Study
Arief Lalmohamed, PharmD; Peter Vestergaard, MD, PhD, DMSc; Corinne Klop, PharmD; et al.
Arch Intern Med. 2012;172(16):1229-1235. doi:10.1001/archinternmed.2012.2713.
JAMA Internal Medicine | 
Invited Commentary |  September 10, 2012
Risk of Acute Myocardial Infarction in Patients With Total Hip or Knee Replacement:  Comment on “Timing of Acute Myocardial Infarction in Patients Undergoing Total Hip or Knee Replacement: A Nationwide Cohort Study”
Arthur W. Wallace, MD, PhD
Arch Intern Med. 2012;172(16):1235-1236. doi:10.1001/archinternmed.2012.3776.
JAMA | 
Editorial |  September 05, 2012
Antiplatelet Therapy Following Myocardial Infarction in Patients With Diabetes
Deepak L. Bhatt, MD, MPH
JAMA. 2012;308(9):921-922. doi:10.1001/2012.jama.11467.
JAMA | 
Original Contribution |  September 05, 2012 FREE
Association of Clopidogrel Treatment With Risk of Mortality and Cardiovascular Events Following Myocardial Infarction in Patients With and Without Diabetes
Charlotte Andersson, MD, PhD; Stig Lyngbæk, MD; Cu Dinh Nguyen, MD; et al.
JAMA. 2012;308(9):882-889. doi:10.1001/2012.jama.10779.
INCLUDES: , Supplemental Content
JAMA | 
Editorial |  August 22, 2012
New-Generation Drug-Eluting Stents for Patients With Myocardial Infarction
Salvatore Cassese, MD; Adnan Kastrati, MD
JAMA. 2012;308(8):814-815. doi:10.1001/2012.jama.10465.
JAMA | 
Original Contribution |  August 22, 2012 FREE
Common Carotid Intima-Media Thickness Measurements in Cardiovascular Risk Prediction:  A Meta-analysis
Hester M. Den Ruijter, PhD; Sanne A. E. Peters, MSc; Todd J. Anderson, MD; et al.
JAMA. 2012;308(8):796-803. doi:10.1001/jama.2012.9630.
INCLUDES: , Supplemental Content
JAMA | 
Original Contribution |  August 22, 2012 FREE
Effect of Biolimus-Eluting Stents With Biodegradable Polymer vs Bare-Metal Stents on Cardiovascular Events Among Patients With Acute Myocardial Infarction:  The COMFORTABLE AMI Randomized Trial
Lorenz Räber, MD; Henning Kelbæk, MD; Miodrag Ostojic, MD; et al.
JAMA. 2012;308(8):777-787. doi:10.1001/jama.2012.10065.
JAMA | 
Viewpoint |  August 22, 2012
Transforming Quality of Care and Improving Outcomes After Acute MI:  Lessons From the National Registry of Myocardial Infarction
William J. French, MD; Vanessa S. Reddy, MS; Hal V. Barron, MD
JAMA. 2012;308(8):771-772. doi:10.1001/jama.2012.9500.
JAMA | 
Medical News and Perspectives |  July 11, 2012
Study: Acute Coronary Events Linked With PTSD
Rebecca Voelker
JAMA. 2012;308(2):121. doi:10.1001/jama.2012.7948.
JAMA Internal Medicine | 
Invited Commentary |  June 11, 2012
Activating Primary Percutaneous Coronary Intervention for STEMI That Is Not: The Collateral Damage of Improving Door-to-Balloon Time:  Comment on “Prevalence and Factors Associated With False-Positive ST-Segment Elevation Myocardial Infarction Diagnoses at Primary Percutaneous Coronary Intervention–Capable Centers”
Fouad Bachour, MD; Richard Asinger, MD
Arch Intern Med. 2012;172(11):871. doi:10.1001/archinternmed.2012.1117.
JAMA Internal Medicine | 
Original Investigation |  June 11, 2012
Prevalence and Factors Associated With False-Positive ST-Segment Elevation Myocardial Infarction Diagnoses at Primary Percutaneous Coronary Intervention–Capable Centers:  A Report From the Activate-SF Registry
James M. McCabe, MD; Ehrin J. Armstrong, MD, MSc; Ameya Kulkarni, MD; et al.
Arch Intern Med. 2012;172(11):864-871. doi:10.1001/archinternmed.2012.945.
JAMA | 
Editorial |  June 06, 2012
Hemorrhagic Complications Associated With Aspirin:  An Underestimated Hazard in Clinical Practice?
Jolanta M. Siller-Matula, MD, PhD
JAMA. 2012;307(21):2318-2320. doi:10.1001/jama.2012.6152.
JAMA | 
Viewpoint |  June 06, 2012
Kidney Attack
John A. Kellum, MD; Rinaldo Bellomo, MD; Claudio Ronco, MD
JAMA. 2012;307(21):2265-2266. doi:10.1001/jama.2012.4315.
JAMA Internal Medicine | 
Editor's Correspondence |  May 28, 2012
Dabigatran and Myocardial Infarction: Meta-Illusion?
Arch Intern Med. 2012;172(10):823. doi:10.1001/archinternmed.2012.836.
JAMA Internal Medicine | 
Editor's Correspondence |  May 28, 2012
Dabigatran and Myocardial Infarction: Meta-Illusion?—Reply
Arch Intern Med. 2012;172(10):823. doi:10.1001/archinternmed.2012.1154.
JAMA Internal Medicine | 
Research Letters |  May 14, 2012 FREE
The Increasing Burden of Atrial Fibrillation Compared With Heart Failure and Myocardial Infarction: A 15-Year Study of All Hospitalizations in Australia
Christopher X. Wong, MBBS; Anthony G. Brooks, PhD; Darryl P. Leong, MBBS, MPH, PhD; et al.
Arch Intern Med. 2012;172(9):739-741. doi:10.1001/archinternmed.2012.878.
JAMA Internal Medicine | 
Research Letters |  May 14, 2012 FREE
Invited Commentary—Global Arrhythmia Burden: The Public Health Implications of the Rise in Atrial Fibrillation
Comment on “The Increasing Burden of Atrial Fibrillation Compared With Heart Failure and Myocardial Infarction”
Rajat Deo, MD, MTR; Paul D. Varosy, MD
Arch Intern Med. 2012;172(9):741-742. doi:10.1001/archinternmed.2012.1294.
JAMA | 
Editorial |  May 09, 2012
A New Look at an Old Therapy
Robert M. Califf, MD
JAMA. 2012;307(18):1972-1973. doi:10.1001/jama.2012.4434.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA
From the JAMA Network  |  May 15, 2013
Do TNF Inhibitors Reduce the Risk of Myocardial Infarction in Psoriasis Patients?
April W. Armstrong, MD, MPH
JAMA Internal Medicine
Invited Commentary  |  March 4, 2013
Getting to the Heart of HIV and Myocardial Infarction:  Comment on “HIV Infection and the Risk of Acute Myocardial Infarction”
Patrick W. G. Mallon, MB, BCh, PhD, FRACP, FRCPI
JAMA Internal Medicine
Original Investigation  |  March 4, 2013
HIV Infection and the Risk of Acute Myocardial Infarction
Matthew S. Freiberg, MD, MSc; Chung-Chou H. Chang, PhD; Lewis H. Kuller, MD, DrPH; et al.
JAMA
Original Contribution  |  April 17, 2013
Prevalence of a Healthy Lifestyle Among Individuals With Cardiovascular Disease in High-, Middle- and Low-Income Countries:  The Prospective Urban Rural Epidemiology (PURE) Study
Koon Teo, MB, PhD; Scott Lear, PhD; Shofiqul Islam, MSc; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems